SEI Investments’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $80.3M | Buy |
351,146
+69,673
| +25% | +$15.6M | 0.07% | 287 |
|
|
2025
Q4 | $60M | Buy |
281,473
+76,154
| +37% | +$15.7M | 0.06% | 341 |
|
|
2025
Q3 | $40.8M | Sell |
205,319
-31,251
| -13% | -$5.83M | 0.04% | 441 |
|
|
2025
Q2 | $40.8M | Sell |
236,570
-21,443
| -8% | -$3.49M | 0.05% | 412 |
|
|
2025
Q1 | $40.2M | Sell |
258,013
-5,569
| -2% | -$796K | 0.05% | 388 |
|
|
2024
Q4 | $36.3M | Sell |
263,582
-10,165
| -4% | -$1.34M | 0.05% | 423 |
|
|
2024
Q3 | $40.9M | Buy |
273,747
+9,176
| +3% | +$1.24M | 0.05% | 381 |
|
|
2024
Q2 | $36.1M | Sell |
264,571
-81,615
| -24% | -$11.1M | 0.05% | 382 |
|
|
2024
Q1 | $52.3M | Sell |
346,186
-15,644
| -4% | -$2.23M | 0.08% | 279 |
|
|
2023
Q4 | $45.6M | Sell |
361,830
-34,610
| -9% | -$3.45M | 0.07% | 297 |
|
|
2023
Q3 | $37.1M | Sell |
396,440
-13,944
| -3% | -$1.3M | 0.07% | 310 |
|
|
2023
Q2 | $36.6M | Sell |
410,384
-65,637
| -14% | -$5.71M | 0.06% | 324 |
|
|
2023
Q1 | $51M | Buy |
476,021
+38,770
| +9% | +$4.44M | 0.09% | 222 |
|
|
2022
Q4 | $53.4M | Sell |
437,251
-36,268
| -8% | -$4.21M | 0.12% | 176 |
|
|
2022
Q3 | $48.9M | Buy |
473,519
+21,718
| +5% | +$2.06M | 0.11% | 190 |
|
|
2022
Q2 | $42M | Buy |
451,801
+7,242
| +2% | +$683K | 0.09% | 233 |
|
|
2022
Q1 | $52.2M | Buy |
444,559
+21,868
| +5% | +$2.53M | 0.1% | 192 |
|
|
2021
Q4 | $56.9M | Buy |
422,691
+33,468
| +9% | +$4.98M | 0.11% | 198 |
|
|
2021
Q3 | $62M | Buy |
389,223
+90,902
| +30% | +$12.4M | 0.13% | 161 |
|
|
2021
Q2 | $39.2M | Buy |
298,321
+35,929
| +14% | +$4.79M | 0.09% | 231 |
|
|
2021
Q1 | $33.8M | Buy |
262,392
+19,290
| +8% | +$2.93M | 0.09% | 232 |
|
|
2020
Q4 | $40.6M | Buy |
243,102
+8,328
| +4% | +$1.38M | 0.1% | 186 |
|
|
2020
Q3 | $36.2M | Buy |
234,774
+84,122
| +56% | +$12.1M | 0.1% | 172 |
|
|
2020
Q2 | $22.3M | Buy |
150,652
+64,466
| +75% | +$8.85M | 0.07% | 279 |
|
|
2020
Q1 | $9.71M | Buy |
86,186
+20,278
| +31% | +$2.63M | 0.04% | 483 |
|
|
2019
Q4 | $9.17M | Buy |
65,908
+899
| +1% | +$99.9K | 0.03% | 619 |
|
|
2019
Q3 | $6.26M | Buy |
65,009
+20,938
| +48% | +$2.34M | 0.02% | 828 |
|
|
2019
Q2 | $5.08M | Buy |
44,071
+18,971
| +76% | +$2.27M | 0.02% | 924 |
|
|
2019
Q1 | $2.95M | Buy |
+25,100
| New | +$2.2M | 0.01% | 1150 |
|
Other funds holding ASND
RCM
ACA